Anti-TRAILR2 (DR5) antibody enhanced the effects of birinapant alone and in combination with TNF-α or TRAIL in HPV(+) HNSCC cell lines. This evidence concerns the gene TNFSF10 and head and neck squamous cell carcinoma.